Quantcast

Latest Pharmaceutical sciences Stories

2014-08-22 23:08:21

For generic drugmakers, Oct. 1 is crunch time and is the date after which all ANDA amendment and prior-approval supplement applications must meet new performance goals under the Generic Drug User Fee Amendments (GDUFA) of 2012. Joan Janulis, a Hatch-Waxman pro and all-around expert on FDA regulation in the generic drug industry, will help attendees read between the lines of the GDUFA performance metrics, associated guidance documents and MAPPs, and provide a roadmap to the post-GDUFA...

2014-08-22 23:07:45

On August 19, the FDA announced that certain lots of the Diamondback 360 Peripheral Orbital Atherectomy Systems, by Cardiovascular Systems, are recalled because they may contain sheath that can fracture during use. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-08-22 23:06:27

GTG Technology Group, LLC (GTG), truck-based tablet provider, today published an informative white paper that discusses the power of implementing tablets into a business. Houston,TX (PRWEB) August 22, 2014 Tablets are rapidly gaining popularity across many different industries because of the innovative technology that is used within each device. Tablets utilize multi-touch and capacitive technology to provide users with a handheld computer experience. GTG’s educational white paper,...

2014-08-22 23:06:12

More Than 5,000 Cases Now Being Handled in Massachusetts (PRWEB) August 22, 2014 According to a July 15 article in the Boston Herald, the number of lawsuits involving the use of dialysis products GranuFlo and NaturaLyte being heard in two Massachusetts courts now exceeds 5,000, the national law firm of Baron and Budd reports. The plaintiffs allege that the manufacturer of these products, Fresenius Medical Care – which also owns thousands of dialysis clinics across the United States –...

2014-08-22 23:01:57

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Diabetes Drugs Industry” market research report to its store. Dallas, Texas (PRWEB) August 22, 2014 The Global and China Diabetes Drugs Industry is a professional and in-depth study on the current state of the Diabetes Drug industry in Global and China. The report provides a basic overview of the industry, including definitions, applications and industry chain structure. Global market analysis and Chinese...

2014-08-22 23:01:09

With the stage set for the National Association of Chain Drug Stores (NACDS) Total Store Expo - which will be held in Boston August 23-26 - The Boston Globe published a pro-pharmacy op-ed in its online opinion section, Podium. The op-ed “To improve medical care, enlist pharmacists” is co-authored by Steven C. Anderson, IOM, CAE, president & CEO of NACDS, and Michael Malloy, PharmD, dean of the MCPHS University School of Pharmacy – Worcester/Manchester. Boston, Mass. (PRWEB)...

2014-08-22 16:23:24

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transdermal Film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr. Actavis' ANDA product is a generic version of UCB's Neupro(®), which is indicated for the treatment of signs and symptoms of idiopathic Parkinson's...

2014-08-22 08:24:49

PITTSBURGH, Aug. 22, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of patients with hypokalemia, with or without metabolic...

2014-08-21 23:14:15

In four hours, John Avellanet delivers proven, practical techniques for fast, flexible, flawless inspectional handling and response. Attendees will leave the session with a complete inspection SOP and an observation closure matrix, able to prove to an investigator they’re in a “state-of-control” and, if the worst happens, go from 483 observation to a coveted Untitled Letter without ever triggering a Warning Letter. Falls Church, VA (PRWEB) August 21, 2014 Flawless FDA Inspection...

2014-08-21 23:04:19

The new MedX/XFactor program provides children with chewable vitamins to support healthy habits. Sugar Land, TX (PRWEB) August 21, 2014 When children go back to school, they are exposed to a variety of germs that can cause them to become sick and risk missing school. It is important to make sure children practice healthy habits to help them fight these germs to ensure a successful school year. MedX Pharmacy is helping parents and children to do just that with its XFactor program. The...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related